Lilly’s New Weight-Loss Pill Foundayo Gets Off to a Slow Start
Lilly’s new weight-loss pill started slow, far behind Novo’s, but it’s too early to tell which drug will win.
Already have an account? Sign in.
Lilly’s new weight-loss pill started slow, far behind Novo’s, but it’s too early to tell which drug will win.
The firm initiated Overweight coverage citing strong divesiran Phase 2 potential and 160%+ upside.
Board forms special committee to evaluate the offer.
Sunrun, Tesla, and Renew Home partner to create the largest U.S. virtual power plant with 16GW from home batteries and smart thermostats — powering AI data centers without new infrastructure.